Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
18 The solution was a collaboration where the first-to-file status was monetized through a partnership, allowing the generic version to launch despite the primary manufacturers regulatory issues
Widemann was interviewed by one of her patients, Aidan, who lives with NF1 and was on the selumetinib clinical trial for many years, and she also speaks about the future beyond MEK at the Children's Tumor Foundation 2019 NF Conference
Histidine and methionine are oxidation-prone
Future research should focus on patient-specific responses, genetic factors, and long-term outcomes to refine treatment approaches
Glickman says
US$ 29.10
US$ 25.05
US$ 24.63
US$ 27.23
US$ 23.81
US$ 26.70
